Substituted anilide ligands for the thyroid receptor
Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MALM JOHAN GARG NEERAJ RYONO DENIS E RAHIMI-GHADIM MAHMOUD ELLSWORTH BRUCE A WASHBURN WILLIAM N ERICSSON THOMAS MENG WEI |
| description | Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2004180940A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2004180940A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2004180940A13</originalsourceid><addsrcrecordid>eNrjZDAJLk0qLsksKS1JTVFIzMvMyUxJVcjJTE_MSylWSMsvUijJSAXiyqL8zBSFotTk1IKS_CIeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGBiaGFgaWLgaGhMnCoAENkuDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted anilide ligands for the thyroid receptor</title><source>esp@cenet</source><creator>MALM JOHAN ; GARG NEERAJ ; RYONO DENIS E ; RAHIMI-GHADIM MAHMOUD ; ELLSWORTH BRUCE A ; WASHBURN WILLIAM N ; ERICSSON THOMAS ; MENG WEI</creator><creatorcontrib>MALM JOHAN ; GARG NEERAJ ; RYONO DENIS E ; RAHIMI-GHADIM MAHMOUD ; ELLSWORTH BRUCE A ; WASHBURN WILLIAM N ; ERICSSON THOMAS ; MENG WEI</creatorcontrib><description>Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.</description><edition>7</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040916&DB=EPODOC&CC=US&NR=2004180940A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040916&DB=EPODOC&CC=US&NR=2004180940A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MALM JOHAN</creatorcontrib><creatorcontrib>GARG NEERAJ</creatorcontrib><creatorcontrib>RYONO DENIS E</creatorcontrib><creatorcontrib>RAHIMI-GHADIM MAHMOUD</creatorcontrib><creatorcontrib>ELLSWORTH BRUCE A</creatorcontrib><creatorcontrib>WASHBURN WILLIAM N</creatorcontrib><creatorcontrib>ERICSSON THOMAS</creatorcontrib><creatorcontrib>MENG WEI</creatorcontrib><title>Substituted anilide ligands for the thyroid receptor</title><description>Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAJLk0qLsksKS1JTVFIzMvMyUxJVcjJTE_MSylWSMsvUijJSAXiyqL8zBSFotTk1IKS_CIeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGBiaGFgaWLgaGhMnCoAENkuDg</recordid><startdate>20040916</startdate><enddate>20040916</enddate><creator>MALM JOHAN</creator><creator>GARG NEERAJ</creator><creator>RYONO DENIS E</creator><creator>RAHIMI-GHADIM MAHMOUD</creator><creator>ELLSWORTH BRUCE A</creator><creator>WASHBURN WILLIAM N</creator><creator>ERICSSON THOMAS</creator><creator>MENG WEI</creator><scope>EVB</scope></search><sort><creationdate>20040916</creationdate><title>Substituted anilide ligands for the thyroid receptor</title><author>MALM JOHAN ; GARG NEERAJ ; RYONO DENIS E ; RAHIMI-GHADIM MAHMOUD ; ELLSWORTH BRUCE A ; WASHBURN WILLIAM N ; ERICSSON THOMAS ; MENG WEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2004180940A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MALM JOHAN</creatorcontrib><creatorcontrib>GARG NEERAJ</creatorcontrib><creatorcontrib>RYONO DENIS E</creatorcontrib><creatorcontrib>RAHIMI-GHADIM MAHMOUD</creatorcontrib><creatorcontrib>ELLSWORTH BRUCE A</creatorcontrib><creatorcontrib>WASHBURN WILLIAM N</creatorcontrib><creatorcontrib>ERICSSON THOMAS</creatorcontrib><creatorcontrib>MENG WEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MALM JOHAN</au><au>GARG NEERAJ</au><au>RYONO DENIS E</au><au>RAHIMI-GHADIM MAHMOUD</au><au>ELLSWORTH BRUCE A</au><au>WASHBURN WILLIAM N</au><au>ERICSSON THOMAS</au><au>MENG WEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted anilide ligands for the thyroid receptor</title><date>2004-09-16</date><risdate>2004</risdate><abstract>Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2004180940A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Substituted anilide ligands for the thyroid receptor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A07%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MALM%20JOHAN&rft.date=2004-09-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2004180940A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |